A randomized phase III study comparing induction chemotherapy to daily low dose Cisplatin both combined with high dose radiotherapy in patients with inoperable non-small cell lung cancer stage I, II and III.
Completed
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. Pathologically confirmed Non-small cell lung cancer;
2. Medically inoperable or irresectable NSCLC T 1-4, N0-3, M0;
Exclusion Criteria
1. Previous chemotherapy and/or radiotherapy of the chest;
2. Superior Vena cava syndrome;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease-free survival, local control, pattern of recurrence.
- Secondary Outcome Measures
Name Time Method Acute and late toxicity, Quality of Life.